Small nuclear ribonucleoprotein polypeptide E pseudogene 9 (SNRPEP9)

Small nuclear ribonucleoprotein polypeptide E pseudogene 9 (SNRPEP9) is a **pseudogene**, meaning it is a non-coding segment of DNA that closely resembles the sequence of the functional SNRPE gene but is not expected to produce a functional protein due to mutations accumulated over evolution[6][2]. Pseudogenes are generally not considered therapeutic targets (i.e., they are not receptors, enzymes, transporters, etc.)[2][6]. While some pseudogenes have been shown to play regulatory roles—such as influencing gene expression via competitive endogenous RNA activity or non-coding RNA functions—the specific biological roles or disease associations for SNRPEP9 have not been reported, in contrast to other pseudogenes that may act as ceRNAs in cancer or affect gene regulation in other ways[5][4][3]. There is no evidence that SNRPEP9 interacts directly with drugs, serves as a biomarker, or is associated with health safety issues. Key Points: - **SNRPEP9** is not an established drug target or receptor and lacks any noted role in disease or therapy. - The inclusion or referencing of SNRPEP9 as a drug target or molecular receptor is **incorrect**; it is best classified solely as a **pseudogene**[2][6]. - No interacting drugs, mechanisms of action, disease roles, or established biomarker functions are documented for SNRPEP9. - Pseudogenes in general may have biological regulatory functions, but SNRPEP9 specifically has not been implicated in such contexts.

Other names

SNRPE pseudogene 9SNRPEP9Small nuclear ribonucleoprotein polypeptide E pseudogene 9